This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing
Journal of Hematology & Oncology Open Access 12 October 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Accession codes
References
Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003; 17: 277–282.
Hasle H, Niemeyer CM . Advances in the prognostication and management of advanced MDS in children. Br J Haematol 2011; 154: 185–195.
Niemeyer CM, Kratz CP . Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol 2008; 140: 610–624.
Sridhar K, Ross DT, Tibshirani R, Butte AJ, Greenberg PL . Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression. Blood 2009; 114: 4847–4858.
Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG et al. Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells. Leukemia 2010; 24: 756–764.
Mills KI, Kohlmann A, Williams PM, Wieczorek L, Liu WM, Li R et al. Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome (MDS). Blood 2009; 114: 1063–1072.
Roela RA, Carraro DM, Brentani HP, Kaiano JH, Simao DF, Guarnieiro R et al. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes. Leuk Res 2007; 31: 579–589.
Bresolin S, Zecca M, Flotho C, Trentin L, Zangrando A, Sainati L et al. Gene expression-based classification as an independent predictor of clinical outcome in juvenile myelomonocytic leukemia. J Clin Oncol 2010; 28: 1919–1927.
Opgen-Rhein R, Strimmer K . Accurate ranking of differentially expressed genes by a distribution-free shrinkage approach. Stat Appl Genet Mol Biol 2007; 6: Article9.
Veltroni M, Sainati L, Zecca M, Fenu S, Tridello G, Testi AM et al. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? Pediatr Blood Cancer 2009; 52: 357–363.
Kardos G, Baumann I, Passmore SJ, Locatelli F, Hasle H, Schultz KR et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003; 102: 1997–2003.
Haferlach T, Kohlmann A, Wieczorek L, Basso G, Kronnie GT, Bene MC et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol 2010; 28: 2529–2537.
Tamaki H, Ogawa H, Ohyashiki K, Ohyashiki JH, Iwama H, Inoue K et al. The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 1999; 13: 393–399.
Grubach L, Juhl-Christensen C, Rethmeier A, Olesen LH, Aggerholm A, Hokland P et al. Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia. Eur J Haematol 2008; 81: 112–122.
Liu W, Lee HW, Liu Y, Wang R, Rodgers GP . Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2′-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. Blood 2010; 116: 4938–4947.
Acknowledgements
This work was supported by grants from Fondazione Città della Speranza, Padova, Italy (GB, MG), Associazione Italiano Ricerca sul Cancro (GteK, FI, GB), PRIN/programmi di ricerca rilevante interesse nazionale, Roma (GteK, GB). We thank Marta Campo Dell’ Orto for initial study design, Ken Mills for discussing DC model data of pediatric MDC specimens and Anna Leszl for providing cytogenetic data.
Author contributions
SB, GteK wrote the manuscript; SB, LT and MG performed the experiments and analyzed the data; SB designed the study and the experiments; MZ, LS collected patient data and coordinated morphological evaluation of MDS subtypes; FL, GB and GteK supervised the study; FL, GB revised the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Bresolin, S., Trentin, L., Zecca, M. et al. Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia. Leukemia 26, 1717–1719 (2012). https://doi.org/10.1038/leu.2012.35
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.35
This article is cited by
-
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing
Journal of Hematology & Oncology (2020)